Bronchiolar disease associated with gold compounds administration in a patient with rheumatoid arthritis

1Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We report the case of a female patient with rheumatoid arthritis (RA) treated with gold sodium thiomalate and auranofin who developed bronchopulmonary involvement. Chest X-ray films showed diffuse mottled infiltrates and bronchial wall thickness in both lungs. Computed tomography revealed opacities along the thickening of the bronchovascular bundles. The pathologic findings were indistinguishable from those of diffuse panbronchiolitis. After discontinuation of gold compounds and initiation of steroid administration, her subjective symptoms immediately subsided. We conclude that our patient, who had suffered from chronic sinusitis and had a predisposition to bronchiolar disease, had bronchiolar disease induced by gold compounds. © Japan College of Rheumatology and Springer-Verlag Tokyo 2005.

Cite

CITATION STYLE

APA

Hiramatsu, K., Ishizuka, H., & Yamasaki, M. (2005). Bronchiolar disease associated with gold compounds administration in a patient with rheumatoid arthritis. Modern Rheumatology, 15(2), 148–152. https://doi.org/10.1007/s10165-005-0382-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free